NewAmsterdam Pharma Company N.V. Ordinary Shares Long-term Investment Intensity
NewAmsterdam Pharma Company N.V. Ordinary Shares long-term investment intensity. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Long-term Investment Intensity of 6.8% as of September 2025. Long-term investments of $53.09 Million represent 6.8% of total assets of $786.43 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See NewAmsterdam Pharma Company N.V. Ordinar current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
NewAmsterdam Pharma Company N.V. Ordinary Shares Long-term Investment Intensity by Year (None–None)
NewAmsterdam Pharma Company N.V. Ordinary Shares long-term investment intensity by year from None to None. The table below presents the year-by-year Long-term Investment Intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NAMS total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|